Review: taking Meclizine and Methadone hydrochloride together


Summary

Drug interactions are reported among people who take Meclizine and Methadone hydrochloride together. This review analyzes the effectiveness and drug interactions between Meclizine and Methadone hydrochloride. It is created by eHealthMe based on reports of 94 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meclizine

Meclizine has active ingredients of meclizine hydrochloride. It is often used in dizziness. (latest outcomes from Meclizine 8,783 users)

Methadone Hydrochloride

Methadone hydrochloride has active ingredients of methadone hydrochloride. It is often used in pain. (latest outcomes from Methadone hydrochloride 3,248 users)

On Sep, 17, 2016

94 people who take Meclizine, Methadone Hydrochloride are studied.


Number of reports submitted per year:

Meclizine and Methadone hydrochloride drug interactions.

Drug effectiveness over time:

Meclizine:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Methadone Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Meclizine:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 0 people)
Methadone Hydrochloride:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Meclizine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Methadone Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

6 - 12 months:
  • asthenia
  • fall
  • hypersomnia
  • lethargy
1 - 2 years:
  • long-term memory loss
  • short-term memory loss
  • sleep
  • sleepiness
  • wheezing
2 - 5 years:
  • long-term memory loss
  • short-term memory loss
  • sleep
  • sleepiness
  • wheezing
not specified:
  • pain
  • back pain
  • arthralgia
  • dyspnoea
  • anxiety
  • pain in extremity
  • cataract
  • diverticulum
  • neuropathy peripheral
  • visual impairment

Most common drug interactions by gender *:

female:
  • serotonin syndrome
  • pain
  • headache
  • fall
  • nausea
  • back pain
  • urinary tract infection
  • arthralgia
  • drug ineffective
  • anxiety
male:
  • dyspnoea
  • pain
  • arthralgia
  • back pain
  • cataract
  • diverticulum
  • neuropathy peripheral
  • pain in extremity
  • anhedonia
  • anxiety

Most common drug interactions by age *:

20-29:
  • cardio-respiratory arrest
  • influenza like illness
  • multiple sclerosis relapse
  • pain
30-39:
  • serotonin syndrome
  • urinary tract infection
  • back pain
  • drug-induced liver injury
  • fall
  • flank pain
  • hyperbilirubinaemia
  • mental status changes
  • transaminases increased
  • abdominal pain
40-49:
  • pain
  • diabetes mellitus
  • angina pectoris
  • arteriosclerosis
  • arthropathy
  • bradycardia
  • cardiac disorder
  • cardiac failure congestive
  • chest pain
  • coronary artery disease
50-59:
  • headache
  • arthralgia
  • mass
  • diplopia
  • dizziness
  • drug ineffective
  • emotional disorder
  • movement disorder
  • visual impairment
  • blood glucose increased
60+:
  • decubitus ulcer
  • nausea
  • chest pain
  • coronary artery disease
  • dyspnoea
  • pain
  • pneumonia
  • cardiomegaly
  • hip fracture
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meclizine and Methadone hydrochloride?

Can you answer these questions?

More questions for: Meclizine, Methadone hydrochloride

You may be interested in these reviews

More reviews for: Meclizine, Methadone hydrochloride

On eHealthMe, Meclizine (meclizine hydrochloride) is often used to treat dizziness. Methadone hydrochloride (methadone hydrochloride) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.